This issue of EuroIntervention provides an in-depth State-of-the-Art on all aspects of the clinical durability of TAVI; original research on immediate vs staged revascularisation in STEMI patients; the ULTRACOLOR Trial comparing ultrasound-guided femoral puncture to fluoroscopy-guided large-bore femoral puncture; expanded study results for transapical TMVR; viewpoints on both TAVI in moderate aortic stenosis and on subclinical leaflet thrombosis; the rationale and design of WOEST-3 trial; a first-hand account of the use of the Splitter, a valve leaflet modification device; news from the EAPCI; and more...
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)